GLOBOVAX

Pharmaceutical preparations, namely, vaccine for anti-cancer; chemical preparations for anti-cancer; vaccine for human use, namely, for the prevention and treatment of cancer, disorders of the immune system, and infectious diseases; pharmaceutical preparations, namely, anti-cancer preparations; medicines for human purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicinal agent for human use, namely, pharmaceutical preparations for the treatment of infectious diseases and for use in oncology, immune system related diseases and disorders; biological preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; pharmaceutical drugs, namely, drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for the treatment of cancer